Novel inhibitors of anthrax edema factor
- 28 June 2008
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 16 (15), 7225-7233
- https://doi.org/10.1016/j.bmc.2008.06.036
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-LactamaseJournal of Medicinal Chemistry, 2008
- A Protein Structure (or Function ?) InitiativeStructure, 2007
- Disruption of cAMP and Prostaglandin E2Transport by Multidrug Resistance Protein 4 Deficiency Alters cAMP-Mediated Signaling and Nociceptive ResponsePublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2007
- Human Monoclonal Antibody AVP-21D9 to Protective Antigen Reduces Dissemination of the Bacillus anthracis Ames Strain from the Lungs in a Rabbit ModelInfection and Immunity, 2007
- A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitorsBioorganic & Medicinal Chemistry, 2007
- Identification of Hot Spots within Druggable Binding Regions by Computational Solvent Mapping of ProteinsJournal of Medicinal Chemistry, 2007
- Structure of anthrax edema factor–calmodulin–adenosine 5′-(α,β-methylene)-triphosphate complex reveals an alternative mode of ATP binding to the catalytic siteBiochemical and Biophysical Research Communications, 2004
- Improved protein–ligand docking using GOLDProteins-Structure Function and Bioinformatics, 2003
- Development and validation of a genetic algorithm for flexible dockingJournal of Molecular Biology, 1997
- Aromatic rings act as hydrogen bond acceptorsJournal of Molecular Biology, 1988